Skip to main content
PeptideClinicLocator logoPeptideClinicLocator
The Journal

Peptide Therapy Insights

Evidence-based guides, regulatory updates, and expert perspectives on peptide therapy. Stay informed with the latest research and clinical insights.

More in Guides

CJC-1295 / Ipamorelin Dosing: What Clinics Prescribe and What to Expect
Guides

CJC-1295 / Ipamorelin Dosing: What Clinics Prescribe and What to Expect

Explore the dosing protocols and clinical considerations for CJC-1295 / Ipamorelin, a growth hormone secretagogue used in anti-aging and recovery treatments.

Read article
PT-141 Dosing: What Clinics Prescribe and What to Expect
Guides

PT-141 Dosing: What Clinics Prescribe and What to Expect

Explore the dosing protocols for PT-141, an FDA-approved peptide for hypoactive sexual desire disorder, including titration schedules and administration methods.

Read article
Tirzepatide Results: What to Realistically Expect
Guides

Tirzepatide Results: What to Realistically Expect

Explore the realistic expectations and clinical outcomes associated with Tirzepatide therapy for weight loss and type 2 diabetes management.

Read article
Sermorelin Results: What to Realistically Expect
Guides

Sermorelin Results: What to Realistically Expect

Explore the realistic expectations and timelines for results with Sermorelin therapy. Understand clinical data, influencing factors, and how Sermorelin compares to alternatives.

Read article
CJC-1295 / Ipamorelin Results: What to Realistically Expect
Guides

CJC-1295 / Ipamorelin Results: What to Realistically Expect

Explore realistic expectations for CJC-1295 / Ipamorelin therapy, including timelines, outcomes, and factors influencing results.

Read article
PT-141 Results: What to Realistically Expect
Guides

PT-141 Results: What to Realistically Expect

Explore realistic outcomes and expectations for PT-141 peptide therapy, backed by clinical data and expert insights.

Read article
GHK-Cu Results: What to Realistically Expect
Guides

GHK-Cu Results: What to Realistically Expect

Explore realistic expectations and outcomes for GHK-Cu peptide therapy, based on clinical data and patient experiences.

Read article
Semaglutide: 15 Questions Answered by Experts
Guides

Semaglutide: 15 Questions Answered by Experts

Get answers to the most common questions about semaglutide, an FDA-approved GLP-1 receptor agonist used for weight loss and type 2 diabetes.

Read article
Tirzepatide: 15 Questions Answered by Experts
Guides

Tirzepatide: 15 Questions Answered by Experts

Get expert answers to the most commonly asked questions about Tirzepatide, a dual GIP/GLP-1 receptor agonist used for weight loss and type 2 diabetes management.

Read article

Stay Up to Date

New articles on peptide therapy, FDA regulations, and clinic reviews are published regularly. Bookmark this page or check back often.